Categories LATEST, U.S. Markets News
As lira hits rock bottom, Turkey looks to boycott US electronics
With the dispute with Washington pushing the Turkish lira to its lowest ever, President Tayyip Erdogan announced that the Middle-Eastern country would boycott electronic goods from the United States in retaliation.
The Turkish currency had shed over 40% of its value this year, and Erdogan’s push for lower interest rates further led to the lira crashing to an all-time low of 7.24 to US dollar early on Monday.
The slide affected global markets as US and European stocks reacted to it, with investors worrying about banking links to Turkey.
The currency did recover on Tuesday though, trading in the 6.5 range in the morning. Reports suggest that a planned call by the finance minister to console investors is the reason for this revival.
The Turkish president had earlier appealed to the people to sell dollars and euros to help aid the national currency. In a speech to his party members, Erdogan said, “Together with our people, we will stand decisively against the dollar, forex prices, inflation and interest rates. We will protect our economic independence by being tight-knit together.”
Pushing for the boycott on US products, he added, “If they have iPhones, there is Samsung on the other side, and we have our own Vestel here.” Turkish electronics company Vestel’s shares inched 5% higher following this.
Last week, the US raised export tariffs on Turkish metals. Washington also imposed sanctions on two Turkish ministers in relation to a terrorism-related trial of a US pastor Andrew Brunson in the country, further straining diplomatic ties.
The euro made a recovery on Tuesday after incurring losses due to the fall of the lira, but it was not enough to lift European investors – with fears mounting that banks exposing themselves to Turkey could still impact the unified currency.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on